Medications Archives - Best Allergy Medicine HQ

FDA Experts Are Still Puzzled Over Who Should Get Which Covid Shots and When

27/01/2023 mediabest Medications

At a meeting to simplify the nation’s covid vaccination policy, the FDA’s panel of experts could agree on only one

More States to Consider Extending Postpartum Medicaid Coverage Beyond Two Months

08/12/2022 mediabest Medications

Lawmakers in several conservative-led states — including Montana, Wyoming, Missouri, and Mississippi — are expected to consider proposals to provide

KHN’s ‘What the Health?’: Kansas Makes a Statement

04/08/2022 mediabest Medications

Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher,

With Overdose Deaths Surging, Advocates on the Ground Push for Over-the-Counter Naloxone

14/12/2021 mediabest Medications

Treatment for addiction is available. For help, call the free and confidential treatment referral hotline (1-800-662-HELP), or visit findtreatment.gov. GREENSBORO,

3 States Limit Nursing Home Profits in Bid to Improve Care

25/10/2021 mediabest Medications

Nursing homes receive billions of taxpayers’ dollars every year to care for chronically ill frail elders, but until now, there

KHN’s ‘What the Health?’: Delta Blues

05/08/2021 mediabest Medications

Can’t see the audio player? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher,

FDA Approves Rezurock

22/07/2021 mediabest Medications

FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE /

FDA Approves Bylvay

22/07/2021 mediabest Medications

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE

Lupin Announces FDA Approval of Supplemental New Drug Application for Solosec (secnidazole) for the Treatment of Trichomoniasis

06/07/2021 mediabest Medications

BALTIMORE, July 1, 2021 /PRNewswire/ –Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin),

FDA Approves Jemperli

25/04/2021 mediabest Medications

FDA Approves Jemperli (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer London UK 22 April 2021 — GlaxoSmithKline today